Helicobacter pylori

Chủ nhật - 15/07/2018 18:00
This book will benefit all gastroenterologists, hematologists, dermatologists, primary care doctors, epidemiologists, physicians who related with community hygiene
Helicobacter pylori By Hidekazu Suzuki, Robin Warren, Barry Marshall
Helicobacter pylori By Hidekazu Suzuki, Robin Warren, Barry Marshall

Helicobacter pylori

This book provides a detailed review of the most recent pathogenetic, diagnostic and therapeutic approaches in connection with Helicobacter pylori, along with priority areas in research and trends in clinical practice to address this significant pathogen acknowledged as the causative agent in a wide range of diseases, including gastric adenocarcinoma, MALT lymphoma and immune thrombocytopenic purpura (ITP). 

Medical authorities worldwide now recommend a “test and treat” strategy for this bacterial infection. Eradication therapy approaches range from general mass eradication therapy to tailor-made therapy for antibiotic-resistant refractory infection. In regions with high prevalence of H. pylori infection, the infection itself would be considered a major parameter to predict the risk of gastric adenocarcinoma development. The main interest has shifted recently to the risk stratification strategy for gastric cancer development and to the wide-ranging application of its serological prevention program. 

This book will benefit all gastroenterologists, hematologists, dermatologists, primary care doctors, epidemiologists, physicians who related with community hygiene, as well as basic scientists, particularly microbiologists, bacteriologists, pathologists, molecular biologists, biochemists, immunologists and oncologists.

Helicobacter pylori By Hidekazu Suzuki, Robin Warren, Barry Marshall
2016, 267 Pages, ISBN: 4431557040, PDF, 5 MB

Tổng số điểm của bài viết là: 0 trong 0 đánh giá

Click để đánh giá bài viết

  Ý kiến bạn đọc

Humana Press

Humana Press Humana Press is an academic publisher of science, technology, and medical books and journals. Humana publishes more than 100 new books and 25 journals per year, with a back list of approximately 1,500 titles in areas such as molecular biology, neuroscience, cancer research, pathology,...

Thăm dò ý kiến

Lợi ích của phần mềm nguồn mở là gì?

Bạn đã không sử dụng Site, Bấm vào đây để duy trì trạng thái đăng nhập. Thời gian chờ: 60 giây